Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.81% | 177.01 | 0.7% | $1390.13m | |
| MRK | Merck & Co., Inc. | -2.60% | 91.96 | 0.7% | $1216.80m | |
| PFE | Pfizer Inc. | -2.29% | 50.69 | 0.9% | $1177.94m | |
| BMY | Bristol-Myers Squibb Co. | -1.58% | 78.72 | 1.0% | $1104.13m | |
| LLY | Eli Lilly & Co. | -2.91% | 317.75 | 1.1% | $1091.72m | |
| ABBV | AbbVie, Inc. | -0.40% | 152.53 | 1.9% | $989.13m | |
| AZN | AstraZeneca Plc | -0.87% | 65.93 | 1.0% | $446.77m | |
| SGEN | Seagen Inc. | 0.42% | 178.47 | 5.7% | $327.62m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.28% | 75.06 | 0.0% | $295.90m | |
| GSK | GSK Plc | -0.78% | 43.36 | 0.2% | $285.09m | |
| HZNP | Horizon Therapeutics Plc | -4.45% | 81.69 | 5.4% | $176.63m | |
| NVS | Novartis AG | -1.27% | 84.20 | 0.2% | $166.38m | |
| MRTX | Mirati Therapeutics, Inc. | -1.67% | 68.50 | 1.6% | $162.75m | |
| NVO | Novo Nordisk A/S | -4.04% | 108.33 | 0.1% | $145.58m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.47% | 144.69 | 0.0% | $142.13m |
Company Profile
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.